[Preliminary animal experimental results and clinical experiences with the antiviral agent adenine arabinoside monophosphate in encephalitis from herpes group and varicella-zoster infections].
D001088:Arabinonucleotides / Q000627:therapeutic use*; D002644:Chickenpox / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004660:Encephalitis / Q000188:drug therapy*; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy*; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D001084:Vidarabine Phosphate / Q000009:adverse effects / Q000627:therapeutic use*
D001088:Arabinonucleotides; D001084:Vidarabine Phosphate
Vorläufige tierexperimentelle und klinische Erfahrungen mit dem Virustaticum Adenin-Arabinosid-Monophosphat bei Encephalitiden aus der Herpesgruppe und bei Varicella/Zoster-Infektionen.